607 Participants Needed

Electrical Nerve Block for Phantom Limb Pain

Recruiting at 22 trial locations
DV
GG
Overseen ByGita Ghadimi
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain.

Will I have to stop taking my current medications?

No, you will not have to stop taking your current medications. The trial requires that you maintain a stable drug regimen for at least 4 weeks before starting and make no changes to your medications during the 3-month primary study period.

What data supports the effectiveness of the Altius System treatment for phantom limb pain?

Research shows that electrical stimulation, similar to the Altius System, has provided excellent or partial relief of phantom limb pain in patients. Additionally, peripheral nerve stimulation, which is a component of the Altius System, has been shown to significantly reduce phantom limb pain in some patients.12345

Is the Electrical Nerve Block treatment safe for humans?

The Altius System, which uses high-frequency nerve block therapy, is being studied for safety in a clinical trial for post-amputation pain. While specific safety data is not detailed, the trial is designed to meet FDA approval standards, suggesting a focus on ensuring safety.14678

How does the Altius System treatment for phantom limb pain differ from other treatments?

The Altius System is unique because it uses a high-frequency nerve block (HFNB) delivered through a cuff electrode on the peripheral nerve and an implantable pulse generator, offering a novel approach compared to traditional methods like short-term nerve blocks or electrical stimulation, which may not provide long-term relief.124910

Research Team

LK

Leonardo Kapural, MD

Principal Investigator

Center for Clinical Research, Winston-Salem NC

Eligibility Criteria

This trial is for adults over 21 with chronic pain after leg amputation, lasting at least 6 months. Candidates must have had their limb amputated for over a year and be on a stable medication regimen without changes to medications or prosthesis planned during the study. Exclusions include those needing MRI post-implant, with active medical devices like pacemakers, untreated major psychological issues, life expectancy under two years, other major pain sources or conditions like uncontrolled diabetes.

Inclusion Criteria

I had one leg amputated over a year ago.
I am 21 years old or older.
My pain episodes usually last an hour or more.
See 3 more

Exclusion Criteria

My spasticity stops me from moving fully.
I have an active infection or a weakened immune system.
You are not expected to live for more than 2 years.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implantation and Initial Testing

Implantation of the Altius System and initial testing of the device

1 month
1 visit (in-person)

Randomized Testing Window

Participants receive either the high frequency bioelectric nerve block or a sham control treatment

2 months
Multiple visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness, including pain reduction and quality of life assessments

12 months
Regular visits (in-person)

Treatment Details

Interventions

  • Altius System
Trial Overview The trial is testing the Altius System's electrical nerve block to see if it safely and effectively reduces pain in patients who have undergone an amputation. Participants will receive this non-drug treatment aimed at managing long-term post-amputation pain.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Test TreatmentExperimental Treatment1 Intervention
Self-initiated high frequency bioelectric nerve block delivered to the nerve by Altius.
Group II: Active Sham Control TreatmentActive Control1 Intervention
Self-initiated non-therapeutic electrical signal delivered to the nerve by Altius.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Neuros Medical, Inc.

Lead Sponsor

Trials
1
Recruited
610+

Findings from Research

In a pilot study involving 21 patients with refractory phantom limb pain, image-guided percutaneous nerve cryoablation demonstrated a 100% technical success rate and was found to be a feasible and safe procedure.
Patients experienced significant reductions in pain intensity, from a mean score of 6.2 to 2.0, and improvements in disability scores, from 11.3 to 3.3, indicating that this treatment may be an effective option for managing phantom limb pain.
Percutaneous Image-Guided Cryoablation for the Treatment of Phantom Limb Pain in Amputees: A Pilot Study.Prologo, JD., Gilliland, CA., Miller, M., et al.[2022]

References

Can neural blocks prevent phantom limb pain? [2014]
Phantom limb pain treated by electrical stimulation. [2021]
Published treatments of phantom limb pain. [2006]
Multicenter, Double-Blinded, Randomized, Active-Sham Controlled Clinical Study Design to Assess the Safety and Effectiveness of a Novel High Frequency Electric Nerve Block System in the Treatment of Post-Amputation Pain (The QUEST Study). [2022]
Peripheral nerve stimulation enables somatosensory feedback while suppressing phantom limb pain in transradial amputees. [2023]
Patient-centered results from a multicenter study of continuous peripheral nerve blocks and postamputation phantom and residual limb pain: secondary outcomes from a randomized, clinical trial. [2023]
Perioperative Anesthetic Techniques to Reduce Surgical Morbidity After Amputation. [2022]
Percutaneous Image-Guided Cryoablation for the Treatment of Phantom Limb Pain in Amputees: A Pilot Study. [2022]
Ultrasound-guided posterior approach to brachial plexus for the treatment of upper phantom limb syndrome. [2022]
[Sciatic nerve block performed with nerve stimulation technique in an amputee--a case study]. [2008]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security